FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37103489> ?p ?o ?g. }

• Q37103489 description "2016 թվականի հուլիսի 12-ին հրատարակված գիտական հոդված" @default.
• Q37103489 description "article científic" @default.
• Q37103489 description "article scientifique" @default.
• Q37103489 description "articolo scientifico" @default.
• Q37103489 description "artigo científico" @default.
• Q37103489 description "artículu científicu espublizáu en 2016" @default.
• Q37103489 description "bilimsel makale" @default.
• Q37103489 description "scientific article published on 12 July 2016" @default.
• Q37103489 description "vedecký článok" @default.
• Q37103489 description "vetenskaplig artikel" @default.
• Q37103489 description "videnskabelig artikel" @default.
• Q37103489 description "vědecký článek" @default.
• Q37103489 description "wetenschappelijk artikel" @default.
• Q37103489 description "wissenschaftlicher Artikel" @default.
• Q37103489 description "наукова стаття, опублікована в липні 2016" @default.
• Q37103489 description "научни чланак" @default.
• Q37103489 description "مقالة علمية نشرت في 12 يوليو 2016" @default.
• Q37103489 name "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus" @default.
• Q37103489 name "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus" @default.
• Q37103489 name "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus." @default.
• Q37103489 type Item @default.
• Q37103489 label "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus" @default.
• Q37103489 label "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus" @default.
• Q37103489 label "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus." @default.
• Q37103489 prefLabel "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus" @default.
• Q37103489 prefLabel "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus" @default.
• Q37103489 prefLabel "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus." @default.
• Q37103489 P1433 Q37103489-02E44BD0-BE97-4D18-8493-747E2B4FD183 @default.
• Q37103489 P1476 Q37103489-999C0D59-A099-4EBA-9312-9A74EE6055DA @default.
• Q37103489 P2093 Q37103489-31E2A195-BAE6-4034-B878-152866D18051 @default.
• Q37103489 P2093 Q37103489-3797D6B7-6CE2-46CE-BA6B-DDC80AB4CE4C @default.
• Q37103489 P2093 Q37103489-559E939A-B25A-45D5-A63F-3A7B986AB4B9 @default.
• Q37103489 P2093 Q37103489-636556ED-9D5F-4AFA-97E3-ACF662417652 @default.
• Q37103489 P2093 Q37103489-8B1F8DA8-32AD-4876-AD7B-67DDE921B593 @default.
• Q37103489 P2093 Q37103489-8C0D2E3C-B8A9-4E32-8A18-4C69469D2DBD @default.
• Q37103489 P2093 Q37103489-FECA3BF2-3579-4624-BEF5-6C20AF90857B @default.
• Q37103489 P275 Q37103489-669948a4-b8ea-48d7-b82b-50733f78bd0e @default.
• Q37103489 P2860 Q37103489-0480BCF9-A1D5-44C5-BE74-B7F2A77581C9 @default.
• Q37103489 P2860 Q37103489-069FFE3E-B1F5-469D-A5D1-B1B7FC00D7C0 @default.
• Q37103489 P2860 Q37103489-1034A53E-183D-4154-90D5-010630BE3B07 @default.
• Q37103489 P2860 Q37103489-108B7ADB-52F1-4507-89E4-DB3AE31C3D31 @default.
• Q37103489 P2860 Q37103489-16FCE7F5-6B83-44EB-877A-7148555B7076 @default.
• Q37103489 P2860 Q37103489-21464EF9-F4E1-46E5-8216-6067F9323280 @default.
• Q37103489 P2860 Q37103489-242AB2C6-9D30-4CDC-9219-6F0F2F921FE5 @default.
• Q37103489 P2860 Q37103489-34F71C03-4876-43B4-B156-BACA5D962F60 @default.
• Q37103489 P2860 Q37103489-3C2160D9-62AB-427E-AFB2-7E2503899A3D @default.
• Q37103489 P2860 Q37103489-3C2C6DC1-8C9F-465F-89FD-2DB192CD6762 @default.
• Q37103489 P2860 Q37103489-542A7FFD-5561-4FA5-867B-F26EBF9C5F14 @default.
• Q37103489 P2860 Q37103489-5D3C9321-1ADF-4023-A16C-EB3F600834B2 @default.
• Q37103489 P2860 Q37103489-682ED007-D2F2-4DB7-BAD1-A72CCF34D2A8 @default.
• Q37103489 P2860 Q37103489-68CF1E84-479B-487B-A9BF-192F750F03A1 @default.
• Q37103489 P2860 Q37103489-7317743D-C558-48CA-9BC9-F64E5AD8A091 @default.
• Q37103489 P2860 Q37103489-74ECF778-2417-46E4-B42C-2B9DFC903796 @default.
• Q37103489 P2860 Q37103489-7929AA6F-B7ED-4EE0-8922-B9410FDA1B5A @default.
• Q37103489 P2860 Q37103489-7D52125D-17D6-49FB-9C14-344B94C54BE1 @default.
• Q37103489 P2860 Q37103489-85F04347-E965-406D-9FDC-BBE37BDF3D15 @default.
• Q37103489 P2860 Q37103489-8FD0A832-34DD-473C-955D-36D4D461170F @default.
• Q37103489 P2860 Q37103489-90DB65B1-0CF5-432F-9951-794773304E74 @default.
• Q37103489 P2860 Q37103489-9D13486C-8F2C-4651-A6E3-916326162941 @default.
• Q37103489 P2860 Q37103489-9F0B3257-F4C5-44E9-9965-A1D23B8A56A1 @default.
• Q37103489 P2860 Q37103489-A29376DA-C88B-4358-A802-00B76D926E92 @default.
• Q37103489 P2860 Q37103489-A83C1F08-EEAC-4179-A9F6-AB45EC516B93 @default.
• Q37103489 P2860 Q37103489-AC61B778-4A59-423A-9599-1DA61A320B64 @default.
• Q37103489 P2860 Q37103489-AF14FC45-F512-41F7-BA5A-D63CFC76648C @default.
• Q37103489 P2860 Q37103489-B4DAA952-2B33-4A58-BBA3-EA4CE88B7993 @default.
• Q37103489 P2860 Q37103489-BAF142C2-AB11-4101-8AC3-2964B45598B1 @default.
• Q37103489 P2860 Q37103489-BB3B3234-70F1-41DE-9E88-4D4F398AC084 @default.
• Q37103489 P2860 Q37103489-BD019411-865E-4651-93E7-95E49C0AA6D5 @default.
• Q37103489 P2860 Q37103489-C64A63FC-78AF-4233-91A2-FE41ADA6B904 @default.
• Q37103489 P2860 Q37103489-CAEC4C3B-C149-4793-9676-E775AE79BD26 @default.
• Q37103489 P2860 Q37103489-CEDC91E0-B044-4902-BF92-23DA2ABE8526 @default.
• Q37103489 P2860 Q37103489-D2BCCFB9-AA54-4B95-B454-8AEC33CBE4AF @default.
• Q37103489 P2860 Q37103489-D3129AB0-BFC7-4678-8E37-6007D01E63AC @default.
• Q37103489 P2860 Q37103489-D47C6604-BC80-47C0-94C2-918103E82033 @default.
• Q37103489 P2860 Q37103489-D728107D-DBD6-40DA-97AD-C154E8A9DC26 @default.
• Q37103489 P2860 Q37103489-D8941A45-64D5-466A-ADC0-6A3F78852B08 @default.
• Q37103489 P2860 Q37103489-E8CC63FF-86DC-4654-AC33-3CCA37A93787 @default.
• Q37103489 P2860 Q37103489-F33D0BB7-64F3-43D9-99CB-09D116EEC2F9 @default.
• Q37103489 P2860 Q37103489-F51A2B58-5997-444F-9E2C-2C1A26DFE3BC @default.
• Q37103489 P2860 Q37103489-F7BBEE59-FAC2-43D7-BDF4-A587C2F04E50 @default.
• Q37103489 P2860 Q37103489-FDB1B034-81D7-4F37-AE68-6749C0AA97DF @default.
• Q37103489 P304 Q37103489-3675613D-FC69-4B1C-9174-8B16A814D7BB @default.
• Q37103489 P31 Q37103489-5BAE4A17-D7A0-4868-84C0-C138A53C5F7B @default.
• Q37103489 P356 Q37103489-3D2325B7-2CBF-4FCB-B9B6-CBEFAC62EA53 @default.
• Q37103489 P407 Q37103489-8340DED9-CDE3-4C79-AC18-E99E86702E9B @default.
• Q37103489 P478 Q37103489-A6972599-063D-44F0-996E-8474A1374DB0 @default.
• Q37103489 P50 Q37103489-8A70A646-F1DB-4947-A3A3-9B603259A3A1 @default.
• Q37103489 P50 Q37103489-B5F37A66-B300-4E17-A61A-418ECFA911E6 @default.
• Q37103489 P577 Q37103489-E00ACF5B-4DF8-41EE-94BB-80F2EA472801 @default.
• Q37103489 P6216 Q37103489-03c16a37-96f9-462d-a4e8-b53fd8945dd1 @default.
• Q37103489 P698 Q37103489-FB36FC3C-D6E5-4B9F-872C-AD1B541AC473 @default.
• Q37103489 P921 Q37103489-CF4163C2-0AD7-4262-A549-23A4A0C7E63B @default.
• Q37103489 P932 Q37103489-427DEA90-52F0-48C4-B11C-12B963169AC0 @default.
• Q37103489 P356 OTT.S106659 @default.
• Q37103489 P698 27471398 @default.
• Q37103489 P1433 Q7092081 @default.
• Q37103489 P1476 "Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus" @default.
• Q37103489 P2093 "Cheng-Zuo Xiao" @default.
• Q37103489 P2093 "Jia-Hong Wang" @default.
• Q37103489 P2093 "Li Xu" @default.

• next